ARCHIVES

Phase II Study of Veliparib Improves PFS by 35 Percent

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI’s First “Zero Based” Budget request Asks For $1.036 Billion; Grants Get Extra $1 Million

September 23, 1977

Xeloda As Effective As 5-FU/LV, Five-Year Survival Data Show

September 28, 2007

NCAB Gives Life To Three CBCCP Contractors Marked For Termination; Compromise “Reasonable” – DeVita

May 30, 1980

Clinical Trials Approved By NCI Last Month

March 29, 2002

Advocacy: Journal Club Leader Sought By NBCC

August 22, 1997

Draft of National Action Plan On Breast Cancer Targets Health Care, Research, Policy

March 23, 1994